课题基金 / 基金详情

TARGETED DISRUPTION OF CERULOPLASMIN GENE, AND ITS INFLUENCE ON PANCREATIC B CELL FUNCTION

TARGETED DISRUPTION OF CERULOPLASMIN GENE, AND ITS INFLUENCE ON PANCREATIC B CELL FUNCTION
铜蓝蛋白基因的靶向破坏及其对胰腺 B 细胞功能的影响
批准号:
12671098
负责人:
DAIMON Makoto
金额:
$0.58万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2001

项目摘要

项目成果

DAIMON Makoto的其他基金

相似基金

相关文献

中文摘要
翻译
铜蓝蛋白(Cp)基因被证明与遗传性CP缺乏症(HCD)有关,HCD是一种以神经异常为特征的常染色体隐性遗传病。在许多HCD病例中,2型糖尿病(DM)是该病的首发症状,10-20年后,在40-60岁时出现神经异常。因此,我们假设CP基因是DM的易感基因,尽管目前参与DM发病机制尚不清楚。为了阐明这一假说和机制,如果是真的,我们首先尝试制作一只靶向CP基因中断的小鼠(CP基因敲除小鼠:CP-/-小鼠)。从小鼠基因组文库中分别筛选出2个和4个含有外显子1和外显子2-4的克隆。将这些克隆用于DNA构建。最后,我们构建了敲除CP基因外显子2和3的DNA结构。该DNA构建物含有pGK-neo和nLacZ-polA可供选择。我们将此DNA结构引入ES细胞,制成基因敲除小鼠。
英文摘要
The ceruloplasmin (Cp) gene has been shown to be responsible for hereditary Cp deficiency (HCD), which is an autosomal recessive disease characterized by neurological abnormalities. In many HCD cases, type 2 diabetes (DM) was the first symptom of the disease, and 10 - 20 years later at age 40 - 60 the neurological abnormalities occurred. Therefore, we made hypothesis that the Cp gene is a susceptible gene for DM, although the mechanisms involved in the pathogenesis of the development of DM are not clear at present. To clarify this hypothesis an, if it is true, the mechanisms, we first tried to make a mouse, which has targeted disruption of Cp gene (Cp knock out mouse: Cp -/-mouse). Then, this mouse can be used to clarify the mechanisms involved in the pathogenesis of the development of DM.From a mouse genomic library, we screened 2 and 4 clones containing exon 1 and exons 2-4, respectively. These clones were used to make DNA construct. We finally made a DNA construct to knock out exons 2 and 3 of the Cp gene. This DNA construct contains PGK-neo and nLacZ-polyA for selection. We introduced this DNA construct to ES cells to make knock out mouse.
期刊论文(13)
专著(0)
科研奖励(0)
会议论文
Satoko Moriai, et al.: "Hypoceruloplasminemia in neurological disease"Internal medicine. 40-6. 548-549 (2001)
Satoko Moriai等人:“神经系统疾病中的低铜蓝蛋白血症”内科。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Satoko Moriai: "Hypoceruloplasminemia in neurological disease"Internal Medicine. 40・6. 548-549 (2001)
森合佐藤子:“神经系统疾病中的低铜蓝蛋白血症”内科40・6(2001)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Makoto Daimon, et al: "Increase in serum ceruloplasmin levels is correlated with a decrease of serum nitric oxide levels in type 2 diabetes"Diabetes Care. 23-4. 559-560 (2000)
Makoto Daimon 等人:“2 型糖尿病患者血清铜蓝蛋白水平升高与血清一氧化氮水平降低相关”《糖尿病护理》。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Makoto Daimon: "Increase in serum ceruloplasmin with aging observed in type 2 diabetes"Endocrine Journal. 47・3. 215-219 (2000)
Makoto Daimon:“2 型糖尿病中观察到的血清铜蓝蛋白增加”,内分泌杂志 47・3(2000 年)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 10 条
    Searching genes susceptible for life-style rerated diseases in consideration with gene -environmental relationship
    • 批准号:
      16K09092
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.08万
    • 财政年份:
      2016
    • 负责人:
      DAIMON Makoto
    • 依托单位:
    Searching genes susceptible for life-style related diseases, such as diabetes and hypertension.
    • 批准号:
      20590595
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.08万
    • 财政年份:
      2008
    • 负责人:
      DAIMON Makoto
    • 依托单位:
    Molecular Epidemiological Study for Genetic Factors Susceptible for Type 2 Diabetes
    • 批准号:
      16590863
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.24万
    • 财政年份:
      2004
    • 负责人:
      DAIMON Makoto
    • 依托单位:
    セルロプラスミン遺伝子異常と糖尿病との関連
    • 批准号:
      09671020
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.34万
    • 财政年份:
      1997
    • 负责人:
      DAIMON Makoto
    • 依托单位:
    国内基金
    海外基金
    热激蛋白HSP101新等位变异基因NTRF1(neo-tetraploid rice fertile gene 1)调控新型四倍体水稻高育性的分子机理
    • 批准号:
      32572292
    • 项目类别:
      面上项目
    • 资助金额:
      50.00万元
    • 批准年份:
      2025
    • 负责人:
      刘向东
    • 依托单位:
    综合医疗机构引入Gene-Xpert MTB/RIF技术早期发现传染性肺结核和耐药肺结核的研究
    Brahma related gene 1/Lamin B1通路在糖尿病肾脏疾病肾小管上皮细胞衰老中的作用
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      10.0万元
    • 批准年份:
      2021
    • 负责人:
      龙海波
    • 依托单位:
    降钙素基因相关肽(Calcitonin gene-related peptide, CGRP)对穴位敏化的调节及机制研究
    • 批准号:
      81873385
    • 项目类别:
      面上项目
    • 资助金额:
      59.0万元
    • 批准年份:
      2018
    • 负责人:
      乔海法
    • 依托单位: